Information Provided By:
Fly News Breaks for December 13, 2018
GSK
Dec 13, 2018 | 16:53 EDT
SunTrust analyst John Boris initiated GlaxoSmithKline with a Hold rating and $38 price target, expecting the company's respiratory franchise to stagnate with Advair generic competition expected in the near-term.
News For GSK From the Last 2 Days
There are no results for your query GSK